Oscar Health, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-44.8% vs price
Base Case (Median)
-19.8% vs price
Bull Case (75th pct.)
259.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $19.47 | -38.3% | High (40%) |
| PE Comparable | $31.16 | -1.2% | Medium (25%) |
| Graham Number | $11.32 | -64.1% | Medium (40%) |
| EV/FCF | $360.66 | 1043.1% | Medium (20%) |
Based on 4 out of 8 methods, OSCR appears fairly valued at the current price of $31.55. The base case fair value of $25.31 implies 19.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.